|
|
???tair.name??? >
???browser.page.title.author???
|
"marcellin p"???jsp.browse.items-by-author.description???
Showing items 1-13 of 13 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-09-04T06:12:05Z |
Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report
|
Chan H.L.-Y.; Thompson A.; Martinot-Peignoux M.; Piratvisuth T.; Cornberg M.; Brunetto M.R.; Tillmann H.L.; JIA-HORNG KAO; Jia J.-D.; Wedemeyer H.; Locarnini S.; Janssen H.L.A.; Marcellin P. |
| 臺大學術典藏 |
2021-09-04T06:11:39Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S. |
| 臺大學術典藏 |
2021-07-03T03:33:52Z |
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
|
Chan H.L.Y.;Ahn S.H.;Chang T.-T.;Peng C.-Y.;Wong D.;Coffin C.S.;Lim S.G.;Pei-Jer Chen;Janssen H.L.A.;Marcellin P.;Serfaty L.;Zeuzem S.;Cohen D.;Critelli L.;Xu D.;Wind-Rotolo M.;Cooney E.;Lira-B Study Team; Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study Team |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns, M.;Pol, S.;Jacobson, I.M.;Marcellin, P.;Gordon, S.C.;Peng, C.-Y.;Chang, T.-T.;Everson, G.T.;Heo, J.;Gerken, G.;Yoffe, B.;Towner, W.J.;Bourliere, M.;Metivier, S.;Chu, C.-J.;Sievert, W.;Bronowicki, J.-P.;Thabut, D.;Lee, Y.-J.;Kao, J.-H.;Mcphee, F.;Kopit, J.;Mendez, P.;Linaberry, M.;Hughes, E.;Noviello, S.; JIA-HORNG KAO |
| 中國醫藥大學 |
2015-01 |
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B was associated with unexpected high rate of peripheral neuropathy
|
(Marcellin P)*;(Wursthorn K);(Wedemeyer H);(Chuang WL);(Lau G);(Avila C);彭成元(Cheng-Yuan Peng);(Gane E);(Lim SG);(Fainboim H);(Foster GR);(Safadi R);(Rizzetto M);(Manns M);(Bao W);(Naoumov N) |
| 中國醫藥大學 |
2014-11 |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|
(Manns M)*;(Pol S);(Jacobson IM);(Marcellin P);(Gordon SC);彭成元(Cheng-Yuan Peng);(Chang TT);(Everson GT);(Heo J);(Gerken G);(Yoffe B);(Towner WJ);(Bourliere M);(Metivier S);(Chu CJ);(Sievert W);(Bronowicki JP);(Thabut D);(Lee YJ);(Kao JH);(McPhee F);(Kopit J);(Mendez P);(Linaberry M);(Hughes E);(Noviello S) |
| 高雄醫學大學 |
2011 |
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C.
|
廖運範(長庚)莊萬龍; Liaw YF;Jia JD;Chan HL;Han KH;Tanwandee T;Chuang WL;Tan DM;Chen XY;Gane E;Piratvisuth T;Chen L;Xie Q;Sung JJ;Wat C;Bernaards C;Cui Y;Marcellin P. |
| 國立成功大學 |
2007-11-15 |
Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B
|
Lim, S. G.; Marcellin, P.; Tassopoulos, N.; Hadziyannis, S.; Chang, Ting-Tsung; Tong, M.; Sievert, W.; Hu, P.; Arterburn, S.; Brosgart, C. L. |
| 國立成功大學 |
2006-07 |
Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy
|
Hadziyannis, S. J.; Tassopoulos, N. C.; Chang, Ting-Tsung; Heathcote, J.; Kitis, G.; Rizzetto, M.; Marcellin, P.; Lim, S.; Goodman, Z.; Arterburn, S.; Ma, J.; Borroto-Esoda, K.; Mondou, E.; Chuck, S. L. |
| 國立成功大學 |
2005-06 |
Long-term (3-year) Therapy with Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen Negative Chronic Hepatitis B
|
Hadziyannis, S. J.; Tassopoulos, N. C.; Heathcote, E. J.; Chang, Ting-Tsung; Kitis, G.; Rizzetto, M.; Marcellin, P.; Lim, S. G.; Goodman, Z.; Ma, J.; Arterburn, S.; Xiong, S.; Currie, G.; Brosgart, C. L. |
| 國立成功大學 |
2004-09 |
Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients
|
Cheng, P. N.; Marcellin, P.; Bacon, B.; Farrell, G.; Parsons, I.; Wee, T.; Chang, Ting-Tsung |
| 國立成功大學 |
2002-10 |
48 weeks of adefovir dipivoxil (ADV) results in improvement in fibrosis and decreased progression of fibrosis in a double-blind, randomized, placebo-controlled study for the treatment of patients with HBeAg plus chronic hepatitis B.
|
Goodman, Zack; Marcellin, P; Chang, Ting-Tsung; Lim, Seng-Gee; Tong, Myron; Sievert, W; Shiffman, M; Jeffers, L; Wulfsohn, M; Fallis, R; Fry, J; Brosgart, C |
| 國立成功大學 |
2002-04 |
GS-98-438 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B: 48 week results
|
Hadzivannis, S; Tassopolous, N; Heathcote, E; Chang, Ting-Tsung; Kitis, G; Rizzetto, T; Marcellin, P; Lim, Seng-Gee; Wulfsohn, Michael; Wollman, M; Fry, John; Brosgart, Carol |
Showing items 1-13 of 13 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
